Atopic dermatitis stem cell therapy (Hhandok/SCM Lifescience)

N/A

Report date: 2022/12/25 13:45:28

Base Information

Drug NameAtopic dermatitis stem cell therapy (Hhandok/SCM Lifescience)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsDermatitis, Atopic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesScm Lifescience Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHandok IncScm Lifescience Co Ltd
Inactive CompaniesN/A
Active IndicationsDermatitis, Atopic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A